Clinical Trial Update: Human Vasodilatory Effect of GLP-1 [NA]

View source ↗

Summary

A completed clinical trial assessed the vasodilatory effects of GLP-1 in people with coronary artery disease, type 2 diabetes mellitus, and stable angina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Stable Angina
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Papworth Hospital NHS Foundation Trust | Conditions: Coronary Stenosis, Type2 Diabetes | NA | Status: COMPLETED